PGFC
BMY icon

Peapack-Gladstone Financial Corp’s Bristol-Myers Squibb BMY Stock Holding History

Peapack-Gladstone Financial Corp’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$26.7M Sell
439,535
-10,319
-2% -$602K 0.34% 86
2025
Q4 		$24.3M Sell
449,854
-27,703
-6% -$1.33M 0.31% 86
2025
Q3 		$21.5M Buy
477,557
+18,997
+4% +$887K 0.28% 92
2025
Q2 		$21.2M Sell
458,560
-20,729
-4% -$1.02M 0.3% 89
2025
Q1 		$29.2M Sell
479,289
-5,293
-1% -$309K 0.43% 65
2024
Q4 		$27.4M Sell
484,582
-8,449
-2% -$472K 0.4% 76
2024
Q3 		$25.5M Sell
493,031
-70,311
-12% -$3.3M 0.37% 78
2024
Q2 		$23.4M Sell
563,342
-15,441
-3% -$691K 0.36% 80
2024
Q1 		$31.4M Sell
578,783
-23,312
-4% -$1.19M 0.49% 54
2023
Q4 		$30.9M Sell
602,095
-32,032
-5% -$1.68M 0.52% 51
2023
Q3 		$36.8M Sell
634,127
-3,583
-0.6% -$220K 0.68% 35
2023
Q2 		$40.8M Sell
637,710
-9,845
-2% -$660K 0.73% 30
2023
Q1 		$45.3M Buy
647,555
+3,116
+0.5% +$220K 0.86% 22
2022
Q4 		$46.4M Buy
644,439
+10,717
+2% +$808K 0.91% 20
2022
Q3 		$45.1M Buy
633,722
+37,510
+6% +$2.72M 0.92% 22
2022
Q2 		$45.9M Buy
596,212
+14,197
+2% +$1.08M 1.05% 17
2022
Q1 		$42.5M Buy
582,015
+5,878
+1% +$395K 0.83% 26
2021
Q4 		$35.9M Buy
576,137
+908
+0.2% +$53.3K 0.68% 39
2021
Q3 		$34M Buy
575,229
+33,175
+6% +$2.18M 0.7% 35
2021
Q2 		$36.2M Sell
542,054
-8,045
-1% -$525K 0.87% 28
2021
Q1 		$34.7M Sell
550,099
-7,985
-1% -$497K 0.9% 28
2020
Q4 		$34.6M Buy
558,084
+3,467
+0.6% +$213K 1.04% 26
2020
Q3 		$33.4M Sell
554,617
-10,466
-2% -$630K 1.21% 18
2020
Q2 		$33.2M Buy
565,083
+16,887
+3% +$1.01M 1.32% 17
2020
Q1 		$30.6M Buy
548,196
+35,770
+7% +$2.19M 1.44% 13
2019
Q4 		$32.9M Buy
512,426
+87,606
+21% +$5.02M 1.32% 18
2019
Q3 		$21.5M Sell
424,820
-2,547
-0.6% -$120K 0.93% 37
2019
Q2 		$19.4M Buy
427,367
+42,701
+11% +$1.99M 0.84% 40
2019
Q1 		$18.4M Buy
384,666
+43,193
+13% +$2.15M 0.83% 41
2018
Q4 		$17.8M Buy
341,473
+31,313
+10% +$1.68M 0.91% 36
2018
Q3 		$19.3M Sell
310,160
-1,963
-0.6% -$116K 0.94% 34
2018
Q2 		$17.3M Buy
312,123
+8,444
+3% +$456K 0.9% 36
2018
Q1 		$19.2M Sell
303,679
-6,858
-2% -$441K 1.04% 30
2017
Q4 		$19M Buy
310,537
+18,663
+6% +$1.17M 1.02% 30
2017
Q3 		$18.6M Buy
291,874
+10,322
+4% +$603K 1.07% 27
2017
Q2 		$15.7M Buy
281,552
+9,579
+4% +$521K 0.94% 33
2017
Q1 		$14.8M Buy
271,973
+26,503
+11% +$1.45M 0.91% 36
2016
Q4 		$14.3M Buy
245,470
+31,894
+15% +$1.74M 0.93% 35
2016
Q3 		$11.5M Buy
213,576
+45,316
+27% +$2.91M 0.77% 45
2016
Q2 		$12.4M Buy
168,260
+8,093
+5% +$572K 0.85% 38
2016
Q1 		$10.2M Buy
160,167
+61,063
+62% +$3.85M 0.72% 50
2015
Q4 		$6.82M Sell
99,104
-5,694
-5% -$376K 0.48% 67
2015
Q3 		$6.2M Buy
104,798
+1,095
+1% +$69.5K 0.46% 68
2015
Q2 		$6.9M Buy
103,703
+761
+0.7% +$50.2K 0.48% 67
2015
Q1 		$6.64M Sell
102,942
-2,850
-3% -$178K 0.46% 71
2014
Q4 		$6.24M Sell
105,792
-825
-0.8% -$46.5K 0.44% 72
2014
Q3 		$5.46M Buy
106,617
+930
+0.9% +$46.5K 0.41% 77
2014
Q2 		$5.13M Buy
105,687
+771
+0.7% +$38K 0.39% 79
2014
Q1 		$5.45M Sell
104,916
-2,983
-3% -$159K 0.43% 68
2013
Q4 		$5.73M Sell
107,899
-1,661
-2% -$84.6K 0.46% 66
2013
Q3 		$5.07M Sell
109,560
-5,420
-5% -$238K 0.45% 66
2013
Q2 		$5.14M Buy
+114,980
New +$4.99M 0.47% 66

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Peapack-Gladstone Financial Corp's BMY Position: Q1 2026 in Review

Peapack-Gladstone Financial Corp reduced its Bristol-Myers Squibb (BMY) stake by 2.3% in Q1 2026, selling an estimated $602K and leaving 439,535 shares worth $26.7M. The position accounts for 0.34% of the portfolio, ranked #86.

Peapack-Gladstone Financial Corp first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $46.4M in Q4 2022. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Peapack-Gladstone Financial Corp held 439,535 shares of Bristol-Myers Squibb worth $26.7M as of Q1 2026.
  • Peapack-Gladstone Financial Corp sold 10,319 Bristol-Myers Squibb shares in Q1 2026, an estimated $602K.
  • Bristol-Myers Squibb made up 0.34% of Peapack-Gladstone Financial Corp's portfolio in Q1 2026, its #86 holding.
  • Peapack-Gladstone Financial Corp first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
  • Peapack-Gladstone Financial Corp's Bristol-Myers Squibb position peaked at $46.4M in Q4 2022.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Peapack-Gladstone Financial Corp's 13F filing for Q1 2026, filed 15 May 2026.